Form 4: MYGN Executive Margaret Ancona to Depart in 2025
Executive Departure Filing
Margaret Ancona, EVP of Strategy & Transformation at Myriad Genetics, will cease her role effective November 3, 2025, as reported in a recent Form 4 filing.
Summary
- Margaret Ancona, Executive Vice President, Strategy & Transformation at Myriad Genetics Inc. (MYGN), will no longer serve in her role effective November 3, 2025.
- Following her departure, she will no longer be subject to Section 16 reporting requirements.
- Ancona beneficially owns 127,726 shares of Myriad Genetics Common Stock directly.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reporting a planned executive departure, which is neither inherently positive nor negative without further context regarding the company's strategic plans or succession.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction, beyond the planned executive departure.
Industry Context
This announcement pertains to a specific executive change within Myriad Genetics and does not provide broader insights into industry trends or competitive landscape.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| EVP, Strategy & Transformation | Margaret Ancona | N/A | 11/03/2025 | Cessation of role, no longer subject to Section 16 reporting. |
Stakeholder Impact
- Shareholders: Will be informed of a planned change in senior leadership, specifically the EVP of Strategy & Transformation.
- Employees: May experience future organizational adjustments or leadership transitions within the Strategy & Transformation department.
Key Dates
| Date | Description |
|---|---|
| 11/03/2025 | Effective date Margaret Ancona no longer serves as EVP, Strategy & Transformation. |
| 11/04/2025 | Date Form 4 was signed and filed. |
Keywords
Myriad Genetics, MYGN, Margaret Ancona, Executive Departure, Form 4, Corporate Governance, Strategy & Transformation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.